What is the optimal treatment plan for a patient with decades‑long chronic insomnia and comorbid obstructive sleep apnea who is compliant with continuous positive airway pressure (CPAP) therapy but experiences frequent nocturnal awakenings and difficulty returning to sleep?

Treatment for Chronic Insomnia with Comorbid OSA on CPAP

Cognitive Behavioral Therapy for Insomnia (CBT-I) is the definitive first-line treatment for your patient's chronic insomnia, even though they have comorbid OSA that is being treated with CPAP. 1, 2

Primary Treatment Approach

The 2019 VA/DoD and 2016 American College of Physicians guidelines unequivocally establish CBT-I as superior to pharmacotherapy for chronic insomnia, with equivalent short-term results but superior long-term outcomes 1, 2. This recommendation holds true even in the presence of comorbid conditions like OSA.

Why CBT-I Despite CPAP Compliance

Your patient has comorbid insomnia and sleep apnea (COMISA), which affects 30-50% of sleep clinic patients with OSA 3. Critically, CPAP alone does not adequately treat insomnia symptoms in COMISA patients:

• Middle insomnia (frequent nocturnal awakenings) improves with CPAP, decreasing from 59.4% to 30.7% 4
• Initial and late insomnia symptoms persist regardless of CPAP treatment 4
• Your patient's specific pattern—falling asleep quickly but waking frequently and staying awake for hours—suggests a mixed pattern requiring targeted insomnia treatment

Targeted treatment for both conditions leads to the best outcomes 3, 5. The insomnia component requires its own evidence-based intervention beyond OSA management.

CBT-I Components and Delivery

CBT-I is a multicomponent treatment including:

• Sleep restriction therapy: Limiting time in bed to actual sleep time, then gradually increasing as sleep efficiency improves
• Stimulus control: Strengthening the bed-sleep association and establishing consistent sleep-wake patterns
• Cognitive therapy: Addressing maladaptive thoughts and beliefs about sleep
• Relaxation strategies: Counterarousal techniques
• Sleep hygiene education: As a component (not standalone treatment)

1

Delivery options include face-to-face individual therapy, group therapy, telehealth platforms, or Internet-based programs 1. While evidence is insufficient to definitively recommend one delivery method over another, all formats show efficacy. Choose based on availability and patient preference to maximize engagement.

Brief Behavioral Therapy for Insomnia (BBT-I)

An abbreviated version focusing only on behavioral components (sleep restriction, stimulus control, sleep hygiene) is also effective and may be more accessible 1.

Common Pitfall: Sleep Hygiene Alone

Do not offer sleep hygiene education as standalone treatment—it is ineffective compared to CBT-I and potentially harmful by making patients less receptive to effective behavioral treatments 1. Sleep hygiene is only valuable as one component within comprehensive CBT-I.

Pharmacotherapy: Second-Line Only

If CBT-I alone is unsuccessful, unavailable, or the patient is unwilling to engage, consider adding short-term pharmacotherapy through shared decision-making 1, 2:

Medication Options (in order of preference):

1. Low-dose doxepin (3 or 6 mg): Improves sleep latency, total sleep time, sleep quality, and wake after sleep onset with no significant difference in adverse events versus placebo in short-term trials 1. Note: Suicide risk with low-dose doxepin as a hypnotic is unknown and cannot be excluded.

2. Nonbenzodiazepine BZRAs (zolpidem, zaleplon, eszopiclone): Improve sleep efficiency, sleep onset latency, sleep quality, total sleep time, and wake after sleep onset 1. However, FDA has issued safety warnings about serious injuries from sleep behaviors (sleepwalking, sleep driving) 1.

Critical Limitations of Pharmacotherapy:

• Lack of long-term safety data raises concerns about extended use 1
• CBT-I shows superior long-term outcomes compared to medications 1
• Medications should be used for short courses only 1, 2
• Benzodiazepines are not recommended for COMISA due to respiratory depression risks 5

Verify CPAP Optimization

Before attributing all symptoms to insomnia, ensure CPAP therapy is truly optimized:

• Confirm adequate pressure settings and mask fit
• Review objective adherence data (hours per night, residual AHI)
• Check for residual respiratory events or treatment-emergent central apneas
• Consider whether advanced PAP modes (APAP or BPAP) might be beneficial if standard CPAP is suboptimal 6

One study found adaptive servo-ventilation (ASV) superior to CPAP in complex insomnia patients, with 68% achieving remission versus 24% on CPAP 6. However, this remains investigational and should only be considered if standard CPAP optimization fails.

Treatment Algorithm

1. Initiate CBT-I as first-line treatment (face-to-face, telehealth, or Internet-based based on availability)
2. Verify CPAP optimization concurrently—review adherence data, residual AHI, and consider pressure adjustments
3. Reassess after 4-8 weeks of CBT-I
4. If CBT-I alone insufficient: Add short-term low-dose doxepin (3-6 mg) or nonbenzodiazepine BZRA through shared decision-making, discussing benefits, harms, and costs
5. Continue CBT-I principles even if adding medication—behavioral strategies provide sustained long-term benefit
6. Taper medication once sleep stabilizes, maintaining behavioral interventions

Key Clinical Considerations

• COMISA is associated with worse outcomes than either condition alone, including greater daytime impairment, cardiovascular risk, and mental health burden 5
• Insomnia symptoms predict poor CPAP adherence 4—treating insomnia may improve CPAP compliance
• Decades-long chronicity suggests deeply conditioned patterns requiring the cognitive restructuring that only CBT-I provides
• Frequent awakenings with prolonged wakefulness (your patient's specific pattern) responds particularly well to stimulus control and sleep restriction components of CBT-I
• Avoid long-term hypnotic use given lack of safety data and inferior outcomes compared to CBT-I 1